Patent details

Basic Information

Publication number:

EP2604275

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP121963136

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Plurality of doses of recombinant LAG-3 for use in eliciting a monocyte immune response

French Title of Invention:

Pluralité de doses de la protéine recombinant LAG-3 pour déclencher la réponse immune des monocytes

German Title of Invention:

Mehrere Dosen von rekombinantem LAG-3 zur Auslösung einer Monozyteninmmunreaktion

SPC Number:

Dates

Filing date:

03/10/2008

Grant date:

22/11/2017

EP Publication Date:

19/06/2013

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

22/11/2017

EP B1 Publication Date:

22/11/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

03/10/2018

Expiration date:

03/10/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

15/11/2017

 

 

Name:

Immutep

Address:

Parc Club Orsay 2, Rue Jean Rostand, 91400 Orsay, France (FR)

Inventor

Name:

Triebel, Frédéric

Address:

France (FR)

Priority

Priority Number:

07291214

Priority Date:

05/10/2007

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

A61K 31/337; A61K 31/7052; A61K 38/17; A61P 35/00;

Publication

European Patent Bulletin

Issue number:

201747

Publication date:

22/11/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
28/02/2019	Outgoing Correspondence	1